Loading…

Low Cerebrospinal Fluid Glutamate and Glycine in Refractory Affective Disorder

Background Glutamatergic dysregulation has been documented in schizophrenia but has received less systematic study in affective illness. Methods Cerebrospinal fluid (CSF) levels of the excitatory amino acids glutamate (Glu) and aspartate (Asp) and the N-methyl-D-aspartate (NMDA) receptor modulator,...

Full description

Saved in:
Bibliographic Details
Published in:Biological psychiatry (1969) 2007-01, Vol.61 (2), p.162-166
Main Authors: Frye, Mark A, Tsai, Guochuan E, Huggins, Teresa, Coyle, Joseph T, Post, Robert M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Glutamatergic dysregulation has been documented in schizophrenia but has received less systematic study in affective illness. Methods Cerebrospinal fluid (CSF) levels of the excitatory amino acids glutamate (Glu) and aspartate (Asp) and the N-methyl-D-aspartate (NMDA) receptor modulator, glycine (GLY) were measured by high performance liquid chromatography in 32 patients with refractory affective disorder (16 female/16 male, 12 bipolar I, 12 bipolar II, and 8 unipolar) and in 14 age-matched controls. Results There was a significant reduction in CSF glutamate and glycine in patients versus controls. A diagnosis by sex interaction was present for CSF glycine with lower levels in female patients compared to female controls. Levels of the excitatory amino acids were highly inter-correlated in patients, but not in controls. In patients studied after 6 weeks of lamotrigine, there was a trend for CSF glutamate levels to increase. Conclusions These data suggest that in patients with refractory affective disorder, excitatory amino acids are dysregulated, as exemplified both by the decreased CSF glutamate and glycine and their high intercorrelation compared to controls. Further controlled study of glutamatergic dysregulation and its relationship to the pathophysiology of affective disorders and potential mechanism of action of mood stabilizers appears indicated.
ISSN:0006-3223
1873-2402
DOI:10.1016/j.biopsych.2006.01.024